Structure (Image 01)
Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 67457-390
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 67457-390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Formula (Image 02)
The text provides a figure (Figure 1) showing the proportion of complete responders by Day 10 in pooled studies of two drugs: Zoledronic Acid and Pamidronate. The proportion is represented as a percentage on the y-axis while the two drugs are named on the x-axis. The figure also includes numerical values on the y-axis, ranging from 0% to 100%, and a statistical significance (p-value) of 0.002. The sample size (n) for one of the drugs is also mentioned (n=86).*
Graph (Image 03)
This text describes the composition, storage, and dosage requirements of Zoledronic acid injection, a medication used for intravenous infusion. Each vial contains 4 mg of zoledronic acid, and the medication must be diluted before use. It can be stored in a refrigerated temperature range and must be used within 24 hours after dilution. The instructions warn not to mix the medication with calcium-containing infusion solutions. Dosage guidelines and the manufacturer, Mylan Institutional LLC, are also mentioned. No further details are available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
